Announcements Trials
Browse Landscape

Status

Terminated 4Active not recruiting 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Leukemia 4Breast Neoplasms 4Philadelphia Chromosome 3Neoplasms 3Neoplasm Metastasis 2Leukemia, Myeloid 2Bronchiolitis Obliterans Syndrome 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Translocation, Genetic 1Thymus Neoplasms 1Thymoma 1Pathologic Processes 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Mesothelioma 1Leukemia, Myeloid, Chronic-Phase 1Hematologic Diseases 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Diseases 1Blast Crisis 1

Interventions

Cyclophosphamide 59fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 55Busulfan 42Cyclosporine 39Mycophenolic Acid 35Antilymphocyte Serum 34Filgrastim 32Tacrolimus 31Radiotherapy 31Imatinib Mesylate 28Whole-Body Irradiation 25Methotrexate 24Methylprednisolone 23Cord Blood Stem Cell Transplantation 18sargramostim 16Etoposide 16Dasatinib 16Interferon-alpha 15Cytarabine 15Melphalan 14nilotinib 11Thiotepa 9Therapeutics 9Cyclosporins 9Flow Cytometry 8Psychiatric Rehabilitation 7Polymerase Chain Reaction 6thymoglobulin 5merphos 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Chronic-Phase × bosutinib × Clear all
NCT03885830 2023-01-11

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

UNC Lineberger Comprehensive Cancer Center

Completed
45 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡